Clinical Trials List
2022-10-01 - 2024-03-11
Phase III
Terminated5
-
Trial Applicant
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Ming-Ju Wu Division of Nephrology
- TUNG-MIN YU Division of Nephrology
- 吳軍毅 Division of Nephrology
- 鍾牧圻 Division of Nephrology
- 蔡尚峰 Division of Nephrology
- 徐佳鈿 無
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 何靜淳 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 王敘涵 Division of Urology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 陳建嘉 無
- MENG-KUN TSAI 無
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
25 participants
-
Global
350 participants
